

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycolytic process (GO:0006096) | 5.02605930 |
| 2 | desmosome organization (GO:0002934) | 4.86905012 |
| 3 | glucose 6-phosphate metabolic process (GO:0051156) | 4.82863819 |
| 4 | positive regulation of p38MAPK cascade (GO:1900745) | 4.50687684 |
| 5 | regulation of hippo signaling (GO:0035330) | 4.22796788 |
| 6 | apoptotic process involved in morphogenesis (GO:0060561) | 4.22518268 |
| 7 | polarized epithelial cell differentiation (GO:0030859) | 4.22073894 |
| 8 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.21219239 |
| 9 | response to muramyl dipeptide (GO:0032495) | 4.14160208 |
| 10 | endothelial cell chemotaxis (GO:0035767) | 4.10446378 |
| 11 | regulation of translational fidelity (GO:0006450) | 4.09852900 |
| 12 | activation of MAPKKK activity (GO:0000185) | 4.07914254 |
| 13 | establishment of apical/basal cell polarity (GO:0035089) | 4.04074079 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.02623330 |
| 15 | pre-miRNA processing (GO:0031054) | 3.96828781 |
| 16 | L-serine metabolic process (GO:0006563) | 3.86641440 |
| 17 | regulation of gene silencing by RNA (GO:0060966) | 3.79914562 |
| 18 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.79914562 |
| 19 | regulation of gene silencing by miRNA (GO:0060964) | 3.79914562 |
| 20 | surfactant homeostasis (GO:0043129) | 3.70912404 |
| 21 | heterochromatin organization (GO:0070828) | 3.63993309 |
| 22 | regulation of p38MAPK cascade (GO:1900744) | 3.61942603 |
| 23 | negative regulation of interleukin-2 production (GO:0032703) | 3.61530072 |
| 24 | positive regulation of histone deacetylation (GO:0031065) | 3.60395406 |
| 25 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.57550526 |
| 26 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.52227122 |
| 27 | paraxial mesoderm development (GO:0048339) | 3.49324161 |
| 28 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.49108575 |
| 29 | establishment of monopolar cell polarity (GO:0061162) | 3.49108575 |
| 30 | keratinization (GO:0031424) | 3.45624475 |
| 31 | protein hydroxylation (GO:0018126) | 3.45119122 |
| 32 | peptidyl-lysine dimethylation (GO:0018027) | 3.44769082 |
| 33 | coronary vasculature morphogenesis (GO:0060977) | 3.41452345 |
| 34 | peptidyl-proline hydroxylation (GO:0019511) | 3.39950660 |
| 35 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.38284125 |
| 36 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.36800465 |
| 37 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.31545278 |
| 38 | protein retention in ER lumen (GO:0006621) | 3.27982196 |
| 39 | apoptotic process involved in development (GO:1902742) | 3.25677748 |
| 40 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.23509283 |
| 41 | adherens junction assembly (GO:0034333) | 3.20688282 |
| 42 | ER overload response (GO:0006983) | 3.20302852 |
| 43 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.18539986 |
| 44 | pyruvate metabolic process (GO:0006090) | 3.15787745 |
| 45 | hippo signaling (GO:0035329) | 3.14532909 |
| 46 | lung vasculature development (GO:0060426) | 3.12500374 |
| 47 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.11997727 |
| 48 | ER-nucleus signaling pathway (GO:0006984) | 3.11446120 |
| 49 | homocysteine metabolic process (GO:0050667) | 3.09239613 |
| 50 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.08891063 |
| 51 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.06987475 |
| 52 | cellular response to unfolded protein (GO:0034620) | 3.06524726 |
| 53 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.06510423 |
| 54 | 4-hydroxyproline metabolic process (GO:0019471) | 3.05832270 |
| 55 | tolerance induction (GO:0002507) | 3.05629892 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.03702860 |
| 57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.01999598 |
| 58 | hemidesmosome assembly (GO:0031581) | 3.01095672 |
| 59 | atrioventricular valve morphogenesis (GO:0003181) | 2.99756469 |
| 60 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.99728104 |
| 61 | negative regulation of fatty acid transport (GO:2000192) | 2.94677747 |
| 62 | negative regulation of cell size (GO:0045792) | 2.93869542 |
| 63 | cell-substrate junction assembly (GO:0007044) | 2.93630889 |
| 64 | trophectodermal cell differentiation (GO:0001829) | 2.92751706 |
| 65 | maternal placenta development (GO:0001893) | 2.92415994 |
| 66 | response to laminar fluid shear stress (GO:0034616) | 2.91210989 |
| 67 | nodal signaling pathway (GO:0038092) | 2.91164288 |
| 68 | cellular response to topologically incorrect protein (GO:0035967) | 2.90756301 |
| 69 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.89495647 |
| 70 | negative regulation of histone methylation (GO:0031061) | 2.89030971 |
| 71 | regulation of translational termination (GO:0006449) | 2.88175765 |
| 72 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.88037530 |
| 73 | proline biosynthetic process (GO:0006561) | 2.86708824 |
| 74 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.86677277 |
| 75 | focal adhesion assembly (GO:0048041) | 2.86127579 |
| 76 | cell-substrate adherens junction assembly (GO:0007045) | 2.86127579 |
| 77 | mitotic nuclear envelope reassembly (GO:0007084) | 2.86096018 |
| 78 | nuclear envelope reassembly (GO:0031468) | 2.86096018 |
| 79 | histone H2A monoubiquitination (GO:0035518) | 2.83462041 |
| 80 | NLS-bearing protein import into nucleus (GO:0006607) | 2.82377683 |
| 81 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.82303478 |
| 82 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.80894423 |
| 83 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.80028581 |
| 84 | lung-associated mesenchyme development (GO:0060484) | 2.79797613 |
| 85 | epithelial cell-cell adhesion (GO:0090136) | 2.79563007 |
| 86 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.78807464 |
| 87 | establishment of skin barrier (GO:0061436) | 2.78055556 |
| 88 | positive regulation of vascular permeability (GO:0043117) | 2.77003316 |
| 89 | gluconeogenesis (GO:0006094) | 2.76348447 |
| 90 | mitochondrial DNA metabolic process (GO:0032042) | 2.74353909 |
| 91 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.72682615 |
| 92 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.71775945 |
| 93 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.71775945 |
| 94 | sexual reproduction (GO:0019953) | 2.71707491 |
| 95 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.70473591 |
| 96 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.70158637 |
| 97 | cellular response to interleukin-4 (GO:0071353) | 2.69828860 |
| 98 | labyrinthine layer blood vessel development (GO:0060716) | 2.69705262 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.69445239 |
| 100 | mRNA stabilization (GO:0048255) | 2.67291925 |
| 101 | RNA stabilization (GO:0043489) | 2.67291925 |
| 102 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.67236537 |
| 103 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.66896204 |
| 104 | cytoplasmic sequestering of transcription factor (GO:0042994) | 2.65424996 |
| 105 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.64481879 |
| 106 | regulation of sister chromatid cohesion (GO:0007063) | 2.63243800 |
| 107 | protein localization to endosome (GO:0036010) | 2.60882463 |
| 108 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.59857098 |
| 109 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.59462962 |
| 110 | glial cell proliferation (GO:0014009) | 2.58998057 |
| 111 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.57372994 |
| 112 | nuclear pore organization (GO:0006999) | 2.57162057 |
| 113 | developmental programmed cell death (GO:0010623) | 2.56698408 |
| 114 | ectodermal placode formation (GO:0060788) | 2.56602935 |
| 115 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.55775018 |
| 116 | anterior/posterior axis specification, embryo (GO:0008595) | 2.55716699 |
| 117 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.55554154 |
| 118 | hexose biosynthetic process (GO:0019319) | 2.55362388 |
| 119 | dosage compensation (GO:0007549) | 2.55277174 |
| 120 | mitotic G1/S transition checkpoint (GO:0044819) | 2.55160496 |
| 121 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.54737249 |
| 122 | embryonic process involved in female pregnancy (GO:0060136) | 2.54554137 |
| 123 | peptidyl-arginine methylation (GO:0018216) | 2.54333903 |
| 124 | peptidyl-arginine N-methylation (GO:0035246) | 2.54333903 |
| 125 | regulation of nuclease activity (GO:0032069) | 2.54177039 |
| 126 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.53335912 |
| 127 | regulation of water loss via skin (GO:0033561) | 2.52666364 |
| 128 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.51430785 |
| 129 | positive regulation of mitochondrial fission (GO:0090141) | 2.50622084 |
| 130 | monosaccharide biosynthetic process (GO:0046364) | 2.49406734 |
| 131 | positive regulation of nuclease activity (GO:0032075) | 2.49218538 |
| 132 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.49035620 |
| 133 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.49035620 |
| 134 | regulation of RNA export from nucleus (GO:0046831) | 2.48892473 |
| 135 | positive regulation of protein kinase C signaling (GO:0090037) | 2.48208073 |
| 136 | carbohydrate phosphorylation (GO:0046835) | 2.47963145 |
| 137 | nuclear pore complex assembly (GO:0051292) | 2.47156829 |
| 138 | chromatin assembly (GO:0031497) | 2.46673052 |
| 139 | positive regulation of epidermis development (GO:0045684) | 2.44869642 |
| 140 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.44553223 |
| 141 | negative regulation of catenin import into nucleus (GO:0035414) | 2.44437204 |
| 142 | serine transport (GO:0032329) | 2.43647322 |
| 143 | regulation of early endosome to late endosome transport (GO:2000641) | 2.43281957 |
| 144 | Golgi transport vesicle coating (GO:0048200) | 2.43069618 |
| 145 | COPI coating of Golgi vesicle (GO:0048205) | 2.43069618 |
| 146 | response to endoplasmic reticulum stress (GO:0034976) | 2.42880415 |
| 147 | endothelial tube morphogenesis (GO:0061154) | 2.42642083 |
| 148 | morphogenesis of an endothelium (GO:0003159) | 2.42642083 |
| 149 | regulation of cholesterol homeostasis (GO:2000188) | 2.42425567 |
| 150 | keratinocyte differentiation (GO:0030216) | 2.42206443 |
| 151 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.42002160 |
| 152 | protein heterotrimerization (GO:0070208) | 2.41571945 |
| 153 | regulation of cardioblast proliferation (GO:0003264) | 2.41546349 |
| 154 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.41546349 |
| 155 | embryonic foregut morphogenesis (GO:0048617) | 2.41135646 |
| 156 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.41095921 |
| 157 | regulation of interleukin-2 production (GO:0032663) | 2.40271251 |
| 158 | serine family amino acid biosynthetic process (GO:0009070) | 2.39718013 |
| 159 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.39692689 |
| 160 | regulation of anoikis (GO:2000209) | 2.39585353 |
| 161 | positive regulation of protein deacetylation (GO:0090312) | 2.39560309 |
| 162 | cell migration involved in gastrulation (GO:0042074) | 2.38648273 |
| 163 | myelin maintenance (GO:0043217) | 2.38063317 |
| 164 | regulation of tight junction assembly (GO:2000810) | 2.37693193 |
| 165 | decidualization (GO:0046697) | 2.37634585 |
| 166 | regulation of integrin activation (GO:0033623) | 2.36031424 |
| 167 | mammary gland alveolus development (GO:0060749) | 2.35481336 |
| 168 | photoperiodism (GO:0009648) | 2.35372480 |
| 169 | modulation by symbiont of host cellular process (GO:0044068) | 2.35314389 |
| 170 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.34450020 |
| 171 | cell migration in hindbrain (GO:0021535) | 2.34265755 |
| 172 | negative regulation of bone resorption (GO:0045779) | 2.34162490 |
| 173 | protein localization to kinetochore (GO:0034501) | 2.34146806 |
| 174 | germinal center formation (GO:0002467) | 2.33891084 |
| 175 | gastrulation with mouth forming second (GO:0001702) | 2.33471149 |
| 176 | placenta blood vessel development (GO:0060674) | 2.31266883 |
| 177 | histone H3-K9 demethylation (GO:0033169) | 2.30267376 |
| 178 | anatomical structure regression (GO:0060033) | 2.29494302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.55774264 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.38511103 |
| 3 | * MYC_22102868_ChIP-Seq_BL_Human | 3.13714993 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.03674153 |
| 5 | * TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94544560 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.71736055 |
| 7 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.60236984 |
| 8 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.42507749 |
| 9 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.37892749 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.30289363 |
| 11 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23380522 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22530837 |
| 13 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.17609181 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11868745 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.10042476 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09334230 |
| 17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.07219693 |
| 18 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.07201174 |
| 19 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.06659990 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06326603 |
| 21 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.06230659 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04126604 |
| 23 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.98205468 |
| 24 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.97664045 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96920979 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95143396 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.90189032 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89012356 |
| 29 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.88531042 |
| 30 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.85072715 |
| 31 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.84823797 |
| 32 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84376105 |
| 33 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.82221951 |
| 34 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.81506459 |
| 35 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.81506459 |
| 36 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.81506459 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79001679 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76247986 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75054577 |
| 40 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.74500699 |
| 41 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.72003784 |
| 42 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.69307247 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.68886485 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.67810368 |
| 45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.64308201 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55541745 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55018736 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54888768 |
| 49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50172700 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48782642 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48134634 |
| 52 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.48067835 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47695890 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47393987 |
| 55 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46359022 |
| 56 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.46321231 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45822479 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45160559 |
| 59 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.45016998 |
| 60 | * MAF_26560356_Chip-Seq_TH2_Human | 1.44965087 |
| 61 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.42820706 |
| 62 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40926090 |
| 63 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.39763157 |
| 64 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39505384 |
| 65 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.39437599 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38924995 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37884204 |
| 68 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36322541 |
| 69 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.32795459 |
| 70 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32377265 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31700265 |
| 72 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31167191 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29641764 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29080084 |
| 75 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28535191 |
| 76 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28329835 |
| 77 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27654124 |
| 78 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27619234 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27481177 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27451115 |
| 81 | * MAF_26560356_Chip-Seq_TH1_Human | 1.25823095 |
| 82 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25456505 |
| 83 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24958027 |
| 84 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24538050 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23747443 |
| 86 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.23137408 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22573081 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22124504 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22097656 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22037106 |
| 91 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.21846352 |
| 92 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.21196563 |
| 93 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20787094 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19140399 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18698905 |
| 96 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18217674 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18195332 |
| 98 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.17288857 |
| 99 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17115246 |
| 100 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17115246 |
| 101 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17028830 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16487176 |
| 103 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16202108 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14203336 |
| 105 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13681185 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13299046 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 1.09039176 |
| 108 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07658815 |
| 109 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07601982 |
| 110 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.07261772 |
| 111 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07103266 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04158061 |
| 113 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03955157 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03598938 |
| 115 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03152922 |
| 116 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02838454 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01567086 |
| 118 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00789505 |
| 119 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00691448 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98477753 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96610082 |
| 122 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96497998 |
| 123 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95803034 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95687608 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95314850 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95286380 |
| 127 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.94605297 |
| 128 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94582178 |
| 129 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94424788 |
| 130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93807362 |
| 131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92778560 |
| 132 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.90043143 |
| 133 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89858688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.01642034 |
| 2 | MP0005083_abnormal_biliary_tract | 3.64164999 |
| 3 | MP0000579_abnormal_nail_morphology | 3.57938222 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.47113344 |
| 5 | MP0002009_preneoplasia | 3.16142980 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.10940900 |
| 7 | MP0002653_abnormal_ependyma_morphology | 3.06525278 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.98268738 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.77069277 |
| 10 | MP0004947_skin_inflammation | 2.50458495 |
| 11 | MP0005451_abnormal_body_composition | 2.41932519 |
| 12 | MP0001849_ear_inflammation | 2.39786059 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.36213017 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.35517659 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.21475559 |
| 16 | MP0003436_decreased_susceptibility_to | 2.12809953 |
| 17 | MP0001216_abnormal_epidermal_layer | 2.02489866 |
| 18 | MP0004233_abnormal_muscle_weight | 2.01749659 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.01334436 |
| 20 | MP0004858_abnormal_nervous_system | 1.99599793 |
| 21 | MP0000678_abnormal_parathyroid_gland | 1.97873927 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.87097287 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.85805849 |
| 24 | MP0000733_abnormal_muscle_development | 1.82108156 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.79491683 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.78957471 |
| 27 | MP0009278_abnormal_bone_marrow | 1.76022750 |
| 28 | MP0000858_altered_metastatic_potential | 1.74352370 |
| 29 | MP0003283_abnormal_digestive_organ | 1.72688162 |
| 30 | MP0002084_abnormal_developmental_patter | 1.72249693 |
| 31 | MP0008260_abnormal_autophagy | 1.71412341 |
| 32 | MP0004197_abnormal_fetal_growth/weight/ | 1.66910615 |
| 33 | MP0002098_abnormal_vibrissa_morphology | 1.64512367 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.64114998 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.63889138 |
| 36 | MP0009931_abnormal_skin_appearance | 1.62957295 |
| 37 | MP0003045_fibrosis | 1.61371446 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.61098896 |
| 39 | MP0001730_embryonic_growth_arrest | 1.61047074 |
| 40 | MP0003119_abnormal_digestive_system | 1.53823993 |
| 41 | MP0002085_abnormal_embryonic_tissue | 1.51840583 |
| 42 | MP0002234_abnormal_pharynx_morphology | 1.51348724 |
| 43 | MP0010771_integument_phenotype | 1.50869809 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.49598569 |
| 45 | MP0010307_abnormal_tumor_latency | 1.49082462 |
| 46 | MP0000534_abnormal_ureter_morphology | 1.47764771 |
| 47 | MP0005023_abnormal_wound_healing | 1.45827614 |
| 48 | MP0000377_abnormal_hair_follicle | 1.45703294 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.44683618 |
| 50 | MP0005380_embryogenesis_phenotype | 1.44683618 |
| 51 | MP0002086_abnormal_extraembryonic_tissu | 1.42281020 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.41105271 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.40434394 |
| 54 | MP0002006_tumorigenesis | 1.40307287 |
| 55 | MP0003984_embryonic_growth_retardation | 1.38154239 |
| 56 | MP0004272_abnormal_basement_membrane | 1.38008655 |
| 57 | MP0002088_abnormal_embryonic_growth/wei | 1.37847474 |
| 58 | MP0009053_abnormal_anal_canal | 1.37742728 |
| 59 | MP0003123_paternal_imprinting | 1.36429205 |
| 60 | MP0000566_synostosis | 1.35224112 |
| 61 | MP0003115_abnormal_respiratory_system | 1.34743405 |
| 62 | MP0001697_abnormal_embryo_size | 1.33309243 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.32424009 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.30816472 |
| 65 | MP0001348_abnormal_lacrimal_gland | 1.29019695 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.27615570 |
| 67 | MP0004381_abnormal_hair_follicle | 1.27189020 |
| 68 | MP0005275_abnormal_skin_tensile | 1.26205633 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.26052080 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.25696098 |
| 71 | MP0003878_abnormal_ear_physiology | 1.25696098 |
| 72 | MP0000428_abnormal_craniofacial_morphol | 1.25679191 |
| 73 | MP0000685_abnormal_immune_system | 1.24911162 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.23582394 |
| 75 | MP0002925_abnormal_cardiovascular_devel | 1.21802947 |
| 76 | MP0004147_increased_porphyrin_level | 1.21778544 |
| 77 | MP0010630_abnormal_cardiac_muscle | 1.20415163 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19640422 |
| 79 | MP0002080_prenatal_lethality | 1.17733784 |
| 80 | MP0003942_abnormal_urinary_system | 1.17405818 |
| 81 | MP0003077_abnormal_cell_cycle | 1.16988782 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 1.16926845 |
| 83 | MP0000383_abnormal_hair_follicle | 1.16598964 |
| 84 | MP0000003_abnormal_adipose_tissue | 1.16496844 |
| 85 | MP0009840_abnormal_foam_cell | 1.16050432 |
| 86 | MP0003091_abnormal_cell_migration | 1.15198095 |
| 87 | MP0005000_abnormal_immune_tolerance | 1.13368397 |
| 88 | MP0000750_abnormal_muscle_regeneration | 1.07168238 |
| 89 | MP0003935_abnormal_craniofacial_develop | 1.06763056 |
| 90 | MP0002092_abnormal_eye_morphology | 1.06080054 |
| 91 | MP0005375_adipose_tissue_phenotype | 1.05856933 |
| 92 | MP0003303_peritoneal_inflammation | 1.04654667 |
| 93 | MP0005058_abnormal_lysosome_morphology | 1.02558344 |
| 94 | MP0001915_intracranial_hemorrhage | 1.01676832 |
| 95 | MP0005257_abnormal_intraocular_pressure | 1.01163623 |
| 96 | MP0003111_abnormal_nucleus_morphology | 1.01140666 |
| 97 | MP0006054_spinal_hemorrhage | 0.99603305 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.98808626 |
| 99 | MP0004885_abnormal_endolymph | 0.98213155 |
| 100 | MP0002697_abnormal_eye_size | 0.97927357 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.96969233 |
| 102 | MP0002111_abnormal_tail_morphology | 0.96420082 |
| 103 | MP0010678_abnormal_skin_adnexa | 0.94796906 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 0.94230842 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.94042472 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.93822244 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.93621589 |
| 108 | MP0000627_abnormal_mammary_gland | 0.93201799 |
| 109 | MP0008770_decreased_survivor_rate | 0.93103956 |
| 110 | MP0002796_impaired_skin_barrier | 0.93010492 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.92115156 |
| 112 | MP0005621_abnormal_cell_physiology | 0.92066787 |
| 113 | MP0000367_abnormal_coat/_hair | 0.91227599 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.89980919 |
| 115 | MP0005501_abnormal_skin_physiology | 0.88921671 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.88682443 |
| 117 | MP0003279_aneurysm | 0.87938683 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.87494789 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 0.87494789 |
| 120 | MP0006138_congestive_heart_failure | 0.87426158 |
| 121 | MP0001243_abnormal_dermal_layer | 0.87270629 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.86235441 |
| 123 | MP0003861_abnormal_nervous_system | 0.85785701 |
| 124 | MP0003385_abnormal_body_wall | 0.85227680 |
| 125 | MP0003329_amyloid_beta_deposits | 0.84809455 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.84549687 |
| 127 | MP0001293_anophthalmia | 0.84431043 |
| 128 | MP0001661_extended_life_span | 0.84194007 |
| 129 | MP0000266_abnormal_heart_morphology | 0.83425469 |
| 130 | MP0008007_abnormal_cellular_replicative | 0.81959614 |
| 131 | MP0002269_muscular_atrophy | 0.81551276 |
| 132 | MP0003937_abnormal_limbs/digits/tail_de | 0.81499082 |
| 133 | MP0001340_abnormal_eyelid_morphology | 0.80720224 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.80283484 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.80199161 |
| 136 | MP0000432_abnormal_head_morphology | 0.80134186 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.80060703 |
| 138 | MP0005187_abnormal_penis_morphology | 0.79987958 |
| 139 | MP0002933_joint_inflammation | 0.79751651 |
| 140 | MP0002932_abnormal_joint_morphology | 0.79463206 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.78814903 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.77628023 |
| 143 | MP0001784_abnormal_fluid_regulation | 0.77543556 |
| 144 | MP0003755_abnormal_palate_morphology | 0.77262882 |
| 145 | MP0002722_abnormal_immune_system | 0.76858289 |
| 146 | MP0002723_abnormal_immune_serum | 0.76524685 |
| 147 | MP0004808_abnormal_hematopoietic_stem | 0.76448482 |
| 148 | * MP0001614_abnormal_blood_vessel | 0.75918594 |
| 149 | MP0001191_abnormal_skin_condition | 0.75148100 |
| 150 | MP0002060_abnormal_skin_morphology | 0.74874797 |
| 151 | MP0003315_abnormal_perineum_morphology | 0.74050692 |
| 152 | MP0002398_abnormal_bone_marrow | 0.72984542 |
| 153 | MP0009672_abnormal_birth_weight | 0.72189814 |
| 154 | MP0005171_absent_coat_pigmentation | 0.71232308 |
| 155 | MP0000703_abnormal_thymus_morphology | 0.71216101 |
| 156 | MP0002019_abnormal_tumor_incidence | 0.67349804 |
| 157 | MP0005394_taste/olfaction_phenotype | 0.66943089 |
| 158 | MP0005499_abnormal_olfactory_system | 0.66943089 |
| 159 | MP0001853_heart_inflammation | 0.66456051 |
| 160 | MP0002452_abnormal_antigen_presenting | 0.64659347 |
| 161 | MP0010155_abnormal_intestine_physiology | 0.62622809 |
| 162 | MP0002429_abnormal_blood_cell | 0.61382666 |
| 163 | MP0002148_abnormal_hypersensitivity_rea | 0.61159874 |
| 164 | MP0001819_abnormal_immune_cell | 0.60106310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 6.39468196 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 5.92127411 |
| 3 | Cholecystitis (HP:0001082) | 5.92127411 |
| 4 | Onycholysis (HP:0001806) | 4.97395216 |
| 5 | Thick nail (HP:0001805) | 4.37257139 |
| 6 | Plantar hyperkeratosis (HP:0007556) | 4.22047501 |
| 7 | Reticulocytosis (HP:0001923) | 4.17038910 |
| 8 | Fragile nails (HP:0001808) | 4.05102143 |
| 9 | Nail dystrophy (HP:0008404) | 3.81160063 |
| 10 | Shallow orbits (HP:0000586) | 3.61071170 |
| 11 | Hyperacusis (HP:0010780) | 3.54577814 |
| 12 | Alopecia of scalp (HP:0002293) | 3.49546574 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.30694460 |
| 14 | Palmoplantar hyperkeratosis (HP:0000972) | 3.21059683 |
| 15 | Cholelithiasis (HP:0001081) | 3.17667290 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.08374068 |
| 17 | Pterygium (HP:0001059) | 3.03387921 |
| 18 | Increased IgE level (HP:0003212) | 2.99917455 |
| 19 | Abnormality of reticulocytes (HP:0004312) | 2.99629017 |
| 20 | Ependymoma (HP:0002888) | 2.97547143 |
| 21 | Abnormality of the astrocytes (HP:0100707) | 2.95895116 |
| 22 | Astrocytoma (HP:0009592) | 2.95895116 |
| 23 | Abnormal blistering of the skin (HP:0008066) | 2.90870477 |
| 24 | Palmar hyperkeratosis (HP:0010765) | 2.90812831 |
| 25 | Upper limb muscle weakness (HP:0003484) | 2.86619013 |
| 26 | Renal duplication (HP:0000075) | 2.75612142 |
| 27 | Bowel diverticulosis (HP:0005222) | 2.74941004 |
| 28 | Erythema (HP:0010783) | 2.72313484 |
| 29 | Enlarged penis (HP:0000040) | 2.71109597 |
| 30 | Long palpebral fissure (HP:0000637) | 2.60221083 |
| 31 | Ridged nail (HP:0001807) | 2.59340636 |
| 32 | Squamous cell carcinoma (HP:0002860) | 2.58921259 |
| 33 | Bladder diverticulum (HP:0000015) | 2.58548633 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.58411063 |
| 35 | Upper limb amyotrophy (HP:0009129) | 2.58411063 |
| 36 | Hand muscle atrophy (HP:0009130) | 2.58215741 |
| 37 | Abnormal gallbladder morphology (HP:0012437) | 2.55963559 |
| 38 | Ankle contracture (HP:0006466) | 2.50271197 |
| 39 | Abnormality of glycolysis (HP:0004366) | 2.50011264 |
| 40 | Elfin facies (HP:0004428) | 2.47554020 |
| 41 | Lip pit (HP:0100267) | 2.44841014 |
| 42 | Ectropion (HP:0000656) | 2.44027302 |
| 43 | Hypotrichosis (HP:0001006) | 2.43630598 |
| 44 | Atrophic scars (HP:0001075) | 2.40256871 |
| 45 | Hypercortisolism (HP:0001578) | 2.40249074 |
| 46 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.38936223 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38804871 |
| 48 | Ulnar bowing (HP:0003031) | 2.37368498 |
| 49 | Rectal prolapse (HP:0002035) | 2.33269923 |
| 50 | Breast hypoplasia (HP:0003187) | 2.32945262 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.32677252 |
| 52 | Peripheral hypomyelination (HP:0007182) | 2.32181989 |
| 53 | Overriding aorta (HP:0002623) | 2.30675799 |
| 54 | Genu recurvatum (HP:0002816) | 2.28952661 |
| 55 | Insomnia (HP:0100785) | 2.28640711 |
| 56 | Aneurysm (HP:0002617) | 2.25330880 |
| 57 | Renovascular hypertension (HP:0100817) | 2.24201230 |
| 58 | Poikiloderma (HP:0001029) | 2.23157375 |
| 59 | Vertebral compression fractures (HP:0002953) | 2.22207639 |
| 60 | Milia (HP:0001056) | 2.20568334 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.19902396 |
| 62 | Macroorchidism (HP:0000053) | 2.19043043 |
| 63 | Subacute progressive viral hepatitis (HP:0006572) | 2.18857544 |
| 64 | Hammertoe (HP:0001765) | 2.18554580 |
| 65 | Pseudobulbar signs (HP:0002200) | 2.16969888 |
| 66 | Entropion (HP:0000621) | 2.16920071 |
| 67 | Abnormality of the gallbladder (HP:0005264) | 2.15705873 |
| 68 | Increased nuchal translucency (HP:0010880) | 2.15108818 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.13011631 |
| 70 | Oral leukoplakia (HP:0002745) | 2.11080318 |
| 71 | Short 4th metacarpal (HP:0010044) | 2.10820395 |
| 72 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10820395 |
| 73 | Pustule (HP:0200039) | 2.08964245 |
| 74 | Mitral valve prolapse (HP:0001634) | 2.07714232 |
| 75 | Back pain (HP:0003418) | 2.07254441 |
| 76 | Fatigue (HP:0012378) | 2.05806968 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.05691877 |
| 78 | Flat cornea (HP:0007720) | 2.05452444 |
| 79 | Abnormality of the 4th metacarpal (HP:0010012) | 2.00089266 |
| 80 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.99359413 |
| 81 | Gastrointestinal carcinoma (HP:0002672) | 1.99359413 |
| 82 | Increased connective tissue (HP:0009025) | 1.99107145 |
| 83 | Abnormality of the salivary glands (HP:0010286) | 1.98460676 |
| 84 | Natal tooth (HP:0000695) | 1.97486700 |
| 85 | Glioma (HP:0009733) | 1.97457025 |
| 86 | Broad face (HP:0000283) | 1.96090749 |
| 87 | Deviation of the hallux (HP:0010051) | 1.95600411 |
| 88 | Abnormal hair laboratory examination (HP:0003328) | 1.93724615 |
| 89 | Pointed chin (HP:0000307) | 1.93679714 |
| 90 | Biconcave vertebral bodies (HP:0004586) | 1.93052123 |
| 91 | Ankyloglossia (HP:0010296) | 1.91585066 |
| 92 | Selective tooth agenesis (HP:0001592) | 1.91153119 |
| 93 | Atelectasis (HP:0100750) | 1.90760777 |
| 94 | Axonal loss (HP:0003447) | 1.90263986 |
| 95 | Difficulty climbing stairs (HP:0003551) | 1.89762074 |
| 96 | Broad metatarsal (HP:0001783) | 1.89322859 |
| 97 | Hallux valgus (HP:0001822) | 1.87573231 |
| 98 | Elbow flexion contracture (HP:0002987) | 1.86696213 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.86466727 |
| 100 | Aortic aneurysm (HP:0004942) | 1.86338635 |
| 101 | Heterotopia (HP:0002282) | 1.86026489 |
| 102 | Rhabdomyolysis (HP:0003201) | 1.85781522 |
| 103 | Diaphragmatic weakness (HP:0009113) | 1.85684554 |
| 104 | Anonychia (HP:0001798) | 1.85648149 |
| 105 | Myoglobinuria (HP:0002913) | 1.85153742 |
| 106 | Deviation of the thumb (HP:0009603) | 1.83487027 |
| 107 | Blepharitis (HP:0000498) | 1.81564121 |
| 108 | Achilles tendon contracture (HP:0001771) | 1.81326782 |
| 109 | Missing ribs (HP:0000921) | 1.80365828 |
| 110 | White forelock (HP:0002211) | 1.80100083 |
| 111 | Popliteal pterygium (HP:0009756) | 1.78962804 |
| 112 | Vertebral hypoplasia (HP:0008417) | 1.77720605 |
| 113 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.77720605 |
| 114 | Fragile skin (HP:0001030) | 1.77606015 |
| 115 | Growth hormone excess (HP:0000845) | 1.77604236 |
| 116 | Sparse scalp hair (HP:0002209) | 1.77500604 |
| 117 | Intestinal polyp (HP:0005266) | 1.77386570 |
| 118 | Fibroma (HP:0010614) | 1.76174409 |
| 119 | Conical tooth (HP:0000698) | 1.75847641 |
| 120 | Abnormality of oral frenula (HP:0000190) | 1.75811082 |
| 121 | Exercise-induced muscle cramps (HP:0003710) | 1.75289776 |
| 122 | Striae distensae (HP:0001065) | 1.74098816 |
| 123 | Neoplasm of the oral cavity (HP:0100649) | 1.73560725 |
| 124 | Annular pancreas (HP:0001734) | 1.72305323 |
| 125 | Nuclear cataract (HP:0100018) | 1.71982301 |
| 126 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.71962224 |
| 127 | Broad thumb (HP:0011304) | 1.71885975 |
| 128 | Lymphangioma (HP:0100764) | 1.71808054 |
| 129 | Megalocornea (HP:0000485) | 1.71703800 |
| 130 | Advanced eruption of teeth (HP:0006288) | 1.71494582 |
| 131 | Hypertensive crisis (HP:0100735) | 1.70964795 |
| 132 | Corneal erosion (HP:0200020) | 1.70923162 |
| 133 | Proximal placement of thumb (HP:0009623) | 1.70524457 |
| 134 | Myopathic facies (HP:0002058) | 1.69977383 |
| 135 | Intestinal polyposis (HP:0200008) | 1.69759813 |
| 136 | Turricephaly (HP:0000262) | 1.69731105 |
| 137 | Dysautonomia (HP:0002459) | 1.69210977 |
| 138 | Esophageal atresia (HP:0002032) | 1.68890831 |
| 139 | Fibrous tissue neoplasm (HP:0012316) | 1.68624945 |
| 140 | Biliary tract neoplasm (HP:0100574) | 1.68556916 |
| 141 | Septate vagina (HP:0001153) | 1.67853242 |
| 142 | Right ventricular cardiomyopathy (HP:0011663) | 1.67401763 |
| 143 | Increased density of long bones (HP:0006392) | 1.67052149 |
| 144 | Broad palm (HP:0001169) | 1.66945628 |
| 145 | Bowed forearm bones (HP:0003956) | 1.66455616 |
| 146 | Bowing of the arm (HP:0006488) | 1.66455616 |
| 147 | Neurofibrillary tangles (HP:0002185) | 1.66002200 |
| 148 | Aplasia cutis congenita (HP:0001057) | 1.65864673 |
| 149 | Dry hair (HP:0011359) | 1.65399084 |
| 150 | Distal sensory impairment (HP:0002936) | 1.65283345 |
| 151 | Rib fusion (HP:0000902) | 1.63790328 |
| 152 | Arnold-Chiari malformation (HP:0002308) | 1.63630092 |
| 153 | Neoplasm of the heart (HP:0100544) | 1.63121336 |
| 154 | Metaphyseal cupping (HP:0003021) | 1.63083920 |
| 155 | Abnormality of the diencephalon (HP:0010662) | 1.62825195 |
| 156 | Erythroderma (HP:0001019) | 1.62596814 |
| 157 | Basal cell carcinoma (HP:0002671) | 1.62509312 |
| 158 | Difficulty running (HP:0009046) | 1.62466390 |
| 159 | Abnormality of the calcaneus (HP:0008364) | 1.61252637 |
| 160 | Truncus arteriosus (HP:0001660) | 1.60993567 |
| 161 | High anterior hairline (HP:0009890) | 1.60920157 |
| 162 | Vertebral arch anomaly (HP:0008438) | 1.60903482 |
| 163 | Pili torti (HP:0003777) | 1.60575248 |
| 164 | Distal lower limb amyotrophy (HP:0008944) | 1.60245564 |
| 165 | Dysmetric saccades (HP:0000641) | 1.59359664 |
| 166 | Abnormality of the fingernails (HP:0001231) | 1.59117081 |
| 167 | Breech presentation (HP:0001623) | 1.58886638 |
| 168 | Spina bifida occulta (HP:0003298) | 1.58079703 |
| 169 | Hyporeflexia of lower limbs (HP:0002600) | 1.56436985 |
| 170 | Absent eyelashes (HP:0000561) | 1.56431118 |
| 171 | Posterior subcapsular cataract (HP:0007787) | 1.56424280 |
| 172 | Disproportionate tall stature (HP:0001519) | 1.56122921 |
| 173 | Angiofibromas (HP:0010615) | 1.55997281 |
| 174 | Adenoma sebaceum (HP:0009720) | 1.55997281 |
| 175 | Scapular winging (HP:0003691) | 1.55796012 |
| 176 | Bronchomalacia (HP:0002780) | 1.54487519 |
| 177 | Short phalanx of the thumb (HP:0009660) | 1.54075687 |
| 178 | Vertebral clefting (HP:0008428) | 1.53118722 |
| 179 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.52484118 |
| 180 | Short 1st metacarpal (HP:0010034) | 1.52484118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.59046121 |
| 2 | TRIB3 | 4.03297785 |
| 3 | PKN2 | 4.02065829 |
| 4 | EPHA2 | 2.93973516 |
| 5 | PIM2 | 2.81641499 |
| 6 | CDK12 | 2.68240815 |
| 7 | MAP3K10 | 2.56393736 |
| 8 | PDGFRA | 2.40825674 |
| 9 | IRAK3 | 2.39261372 |
| 10 | MST1R | 2.29256555 |
| 11 | PRPF4B | 2.25214650 |
| 12 | MAP3K14 | 2.24741072 |
| 13 | LATS2 | 2.22541813 |
| 14 | PDK2 | 2.14802902 |
| 15 | ICK | 2.07516465 |
| 16 | ARAF | 2.03378104 |
| 17 | LATS1 | 2.01733048 |
| 18 | BCKDK | 1.93559481 |
| 19 | TYRO3 | 1.91140069 |
| 20 | NME2 | 1.86923788 |
| 21 | NEK1 | 1.84607543 |
| 22 | SMG1 | 1.83837295 |
| 23 | DDR2 | 1.81898771 |
| 24 | ALK | 1.80943874 |
| 25 | MAP3K9 | 1.76788789 |
| 26 | RIPK1 | 1.74407258 |
| 27 | ERN1 | 1.73143824 |
| 28 | TTN | 1.71174390 |
| 29 | PTK6 | 1.69359374 |
| 30 | SIK1 | 1.68182332 |
| 31 | RPS6KB2 | 1.67881983 |
| 32 | NEK2 | 1.58635268 |
| 33 | TAOK3 | 1.55165060 |
| 34 | BMX | 1.54815689 |
| 35 | PTK2 | 1.53878987 |
| 36 | TBK1 | 1.53114129 |
| 37 | FLT3 | 1.46154951 |
| 38 | LRRK2 | 1.44513571 |
| 39 | MOS | 1.40420748 |
| 40 | WNK4 | 1.38040100 |
| 41 | MAP3K13 | 1.36060806 |
| 42 | KSR2 | 1.33257945 |
| 43 | MTOR | 1.32824868 |
| 44 | PAK4 | 1.28015146 |
| 45 | RET | 1.22380763 |
| 46 | FGFR4 | 1.20270594 |
| 47 | SCYL2 | 1.16877766 |
| 48 | MAPK11 | 1.16000934 |
| 49 | FGFR1 | 1.15139649 |
| 50 | PDGFRB | 1.13635877 |
| 51 | PRKD3 | 1.11550207 |
| 52 | STK10 | 1.10994582 |
| 53 | MATK | 1.07546051 |
| 54 | LMTK2 | 1.06218524 |
| 55 | CDK6 | 0.99273923 |
| 56 | PAK2 | 0.98177361 |
| 57 | IKBKB | 0.97774143 |
| 58 | RAF1 | 0.91915319 |
| 59 | PASK | 0.89842902 |
| 60 | EPHB1 | 0.87343261 |
| 61 | MET | 0.86612375 |
| 62 | IRAK1 | 0.84381517 |
| 63 | TLK1 | 0.83922445 |
| 64 | FER | 0.83893529 |
| 65 | MAP3K8 | 0.82577042 |
| 66 | EPHB2 | 0.81516085 |
| 67 | TGFBR1 | 0.80374611 |
| 68 | PAK6 | 0.80256380 |
| 69 | NTRK1 | 0.78452284 |
| 70 | CHUK | 0.76674572 |
| 71 | MAPK7 | 0.75338909 |
| 72 | TAOK1 | 0.72387651 |
| 73 | NEK6 | 0.71994366 |
| 74 | SIK3 | 0.71804684 |
| 75 | MAP3K2 | 0.71599917 |
| 76 | TAOK2 | 0.71427486 |
| 77 | CDK8 | 0.70730100 |
| 78 | MAPKAPK3 | 0.69359136 |
| 79 | CDK4 | 0.68520447 |
| 80 | DYRK1B | 0.67965704 |
| 81 | TSSK6 | 0.67062237 |
| 82 | FGFR3 | 0.66235498 |
| 83 | STK3 | 0.65830813 |
| 84 | TESK1 | 0.64878814 |
| 85 | IKBKE | 0.64792012 |
| 86 | BRAF | 0.64703348 |
| 87 | ILK | 0.64348701 |
| 88 | FGFR2 | 0.64111617 |
| 89 | MAP2K2 | 0.63070558 |
| 90 | DMPK | 0.62868950 |
| 91 | MAP3K7 | 0.61000949 |
| 92 | KSR1 | 0.60597338 |
| 93 | GRK6 | 0.59967680 |
| 94 | PRKD2 | 0.52842562 |
| 95 | PAK3 | 0.52154189 |
| 96 | JAK3 | 0.51999708 |
| 97 | SIK2 | 0.49961579 |
| 98 | RPS6KA1 | 0.49911396 |
| 99 | MAP3K6 | 0.49829177 |
| 100 | CDK7 | 0.49792284 |
| 101 | RPS6KA5 | 0.49769078 |
| 102 | JAK1 | 0.49633895 |
| 103 | STK39 | 0.48661245 |
| 104 | MAP4K1 | 0.48552945 |
| 105 | CAMK1D | 0.47587044 |
| 106 | BMPR2 | 0.47282875 |
| 107 | CAMK1G | 0.47038186 |
| 108 | BRD4 | 0.46960140 |
| 109 | AKT2 | 0.46316908 |
| 110 | RPS6KC1 | 0.45246093 |
| 111 | RPS6KL1 | 0.45246093 |
| 112 | TTK | 0.45046677 |
| 113 | MARK2 | 0.43908539 |
| 114 | ZAP70 | 0.42528777 |
| 115 | MAP3K1 | 0.42407232 |
| 116 | MAPKAPK2 | 0.42289247 |
| 117 | RPS6KA4 | 0.41569729 |
| 118 | CHEK1 | 0.41424602 |
| 119 | PRKD1 | 0.41411761 |
| 120 | CLK1 | 0.41371117 |
| 121 | AURKA | 0.41339133 |
| 122 | PRKCH | 0.40794451 |
| 123 | CDC7 | 0.39368276 |
| 124 | RPS6KA2 | 0.38830845 |
| 125 | ERBB2 | 0.38078127 |
| 126 | EPHA3 | 0.37669767 |
| 127 | GSK3A | 0.37283986 |
| 128 | CDC42BPA | 0.36632640 |
| 129 | CDK2 | 0.36093642 |
| 130 | PIM1 | 0.35562577 |
| 131 | MAPKAPK5 | 0.35220747 |
| 132 | RPS6KA6 | 0.35038174 |
| 133 | MAPK3 | 0.34948631 |
| 134 | STK38 | 0.34248084 |
| 135 | PRKCI | 0.33922891 |
| 136 | CSNK1D | 0.33776858 |
| 137 | IRAK4 | 0.33454320 |
| 138 | HIPK2 | 0.32776426 |
| 139 | PAK1 | 0.31931127 |
| 140 | MAPK1 | 0.31090788 |
| 141 | INSR | 0.30857576 |
| 142 | JAK2 | 0.29910716 |
| 143 | TESK2 | 0.29629503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.57488160 |
| 2 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.25374065 |
| 3 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.10894770 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.05823716 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.97105591 |
| 6 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.90577022 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90304566 |
| 8 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.90135811 |
| 9 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.89061933 |
| 10 | Adherens junction_Homo sapiens_hsa04520 | 1.85351694 |
| 11 | Bladder cancer_Homo sapiens_hsa05219 | 1.82610991 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.75651678 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.67871276 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.67333762 |
| 15 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.66718840 |
| 16 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.66610357 |
| 17 | Endometrial cancer_Homo sapiens_hsa05213 | 1.64497595 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.59354705 |
| 19 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.57671974 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.56810945 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.56653608 |
| 22 | Colorectal cancer_Homo sapiens_hsa05210 | 1.52938273 |
| 23 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.52596253 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46664188 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.45281544 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43749186 |
| 27 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.43549719 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39820528 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37787093 |
| 30 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36557248 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.33169697 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31402947 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31310128 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.28852784 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28368380 |
| 36 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.27644226 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24809746 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23631977 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23333137 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22885635 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21981712 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20798631 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20375480 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.19377412 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19327594 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18236675 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.16701936 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16389270 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12563094 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.11689006 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11593065 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08458358 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.06480258 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 1.05899299 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03537275 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03213677 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03005434 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.02985000 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.02872496 |
| 60 | Pathways in cancer_Homo sapiens_hsa05200 | 1.02724187 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00759374 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 1.00686468 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00013518 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99632164 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.99140286 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97394153 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97010106 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97009058 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96894366 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.94259541 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.94190691 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93740534 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92523290 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89604662 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88306491 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88086253 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87495727 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87274916 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86854006 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.86624754 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86263952 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84604008 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.82882695 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.82557989 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.81760070 |
| 86 | Cell cycle_Homo sapiens_hsa04110 | 0.81572878 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81261338 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81201494 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81098693 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80831400 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.80472982 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79599474 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79494640 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.78491102 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77426690 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76221626 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76079804 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75885160 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75855473 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.75276553 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73002336 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72751703 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71551985 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.71379738 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70596280 |
| 106 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70268579 |
| 107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70165007 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.69675902 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.68583781 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68061452 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67559521 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.67189050 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67055882 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.65456990 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64883207 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.64791305 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63897309 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63682319 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63431929 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62607320 |
| 121 | Spliceosome_Homo sapiens_hsa03040 | 0.62318943 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62234878 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61674746 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60637836 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.60148787 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.59867511 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59859467 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59696982 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59548352 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59437513 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59043998 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58335102 |
| 133 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57792095 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57126830 |
| 135 | Base excision repair_Homo sapiens_hsa03410 | 0.56475292 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56425779 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56071648 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53882329 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52147089 |
| 140 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49745544 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.49183835 |
| 142 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49159473 |
| 143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44332605 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.42063168 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41508337 |
| 146 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40448529 |
| 147 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39793538 |

